Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Case-control study of the risk factors for acquisition of Pseudomonas and Proteus species during tigecycline therapy.

Literature DB >> 26100705

Case-control study of the risk factors for acquisition of Pseudomonas and Proteus species during tigecycline therapy.

Ga Eun Park¹, Cheol-In Kang², Yu Mi Wi³, Jae-Hoon Ko¹, Woo Joo Lee¹, Ji Yong Lee¹, Sun Young Cho¹, Young Eun Ha¹, Doo Ryeon Chung¹, Kyong Ran Peck¹, Jae-Hoon Song¹.

Abstract

Tigecycline is an important agent in clinical practice because of its broad-spectrum activity. However, it has no activity against Pseudomonas or Proteus species. We conducted a case-control study to analyze risk factors for the acquisition of Pseudomonas or Proteus spp. during tigecycline therapy. Placement of suction drainage at infected wound sites, ICU stay, and neurologic disease were identified as independent risk factors for the acquisition of Pseudomonas and Proteus spp.

Entities: Chemical Disease

Mesh：

Substances：

Year: 2015 PMID： 26100705 PMCID： PMC4538539 DOI： 10.1128/AAC.04865-14

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

Keyword Cloud
References

18 in total

1. Antimicrobial activity and spectrum of the new glycylcycline, GAR-936 tested against 1,203 recent clinical bacterial isolates.

Authors: A C Gales; R N Jones
Journal: Diagn Microbiol Infect Dis Date: 2000-01 Impact factor: 2.803

2. An innovative technique for intra-abdominal abscess drainage using a sump drain by trocar puncture.

Authors: Guosheng Gu; Jianan Ren; Yujie Yuan; Jun Chen; Yueping Fan; Shougen Cao; Jieshou Li
Journal: Am Surg Date: 2011-08 Impact factor: 0.688

Review 3. The Effect of Vacuum-Assisted Closure on the Bacterial Load and Type of Bacteria: A Systematic Review.

Authors: Aryan S P Patmo; Pieta Krijnen; Wim E Tuinebreijer; Roelf S Breederveld
Journal: Adv Wound Care (New Rochelle) Date: 2014-05-01 Impact factor: 4.730

Review 4. Tigecycline: a glycylcycline antimicrobial agent.

Authors: Thien-Ly Doan; Horatio B Fung; Dhara Mehta; Paul F Riska
Journal: Clin Ther Date: 2006-08 Impact factor: 3.393

5. In vitro and in vivo antibacterial activities of a novel glycylcycline, the 9-t-butylglycylamido derivative of minocycline (GAR-936).

Authors: P J Petersen; N V Jacobus; W J Weiss; P E Sum; R T Testa
Journal: Antimicrob Agents Chemother Date: 1999-04 Impact factor: 5.191

10. Does the application of incisional negative pressure therapy to high-risk wounds prevent surgical site complications? A systematic review.

Authors: Michael J Ingargiola; Lily N Daniali; Edward S Lee
Journal: Eplasty Date: 2013-09-20

Case-control study of the risk factors for acquisition of Pseudomonas and Proteus species during tigecycline therapy.

1. Antimicrobial activity and spectrum of the new glycylcycline, GAR-936 tested against 1,203 recent clinical bacterial isolates.

2. An innovative technique for intra-abdominal abscess drainage using a sump drain by trocar puncture.

Review 3. The Effect of Vacuum-Assisted Closure on the Bacterial Load and Type of Bacteria: A Systematic Review.

Review 4. Tigecycline: a glycylcycline antimicrobial agent.

5. In vitro and in vivo antibacterial activities of a novel glycylcycline, the 9-t-butylglycylamido derivative of minocycline (GAR-936).

6. Effect of tigecycline on normal oropharyngeal and intestinal microflora.

7. Efflux-mediated resistance to tigecycline (GAR-936) in Pseudomonas aeruginosa PAO1.

8. Negative pressure therapy for high-risk abdominal wall reconstruction incisions.

Review 9. Management of complicated infections in the era of antimicrobial resistance: the role of tigecycline.

10. Does the application of incisional negative pressure therapy to high-risk wounds prevent surgical site complications? A systematic review.